Research Partners

Our Mission: Transforming Discovery into Life-Saving Action

Oncimmune Ltd has a single goal: To advance early cancer detection to the greatest extent possible using autoantibody assay technology through the Early Cancer Detection Test EarlyCDT^® 

Help Support Breakthroughs in Early Cancer Detection

The Centre of Excellence for Autoimmunity in Cancer (CEAC) at the University of Nottingham (UK), led by Professor John Robertson, is a "not for profit" academic centre of excellence that has been granted unique access to Oncimmune^®'s technology. CEAC will collaborate with academic institutions to research into early stage cancer.

To drive forward this type of investigative research CEAC will be funded by grant, charitable and private funding in addition to that already committed by Oncimmune^® and the University of Nottingham. If you are interested in any further information on CEAC, including becoming a partner, please contact us.

Scientific Advisory Board (SAB)

SAB is a group of international experts who provide Oncimmune with expertise and guidance. To see more information, please visit Scientific Advisory Board page.